Open | - |
Close | - |
Volume / Avg. | 0 / 29.349K |
Day Range | - - - |
52 Wk Range | 0.961 - 3.850 |
Market Cap | $53.244M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 32 |
Short Interest | 0.45% |
Days to Cover | 4.76 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of InspireMD (NASDAQ: NSPR) through any online brokerage.
Other companies in InspireMD’s space includes: RxSight (NASDAQ:RXST), TELA Bio (NASDAQ:TELA), Meihua Intl Medical Techs (NASDAQ:MHUA), Embecta (NASDAQ:EMBC) and NexGel (NASDAQ:NXGL).
The latest price target for InspireMD (NASDAQ: NSPR) was reported by Piper Sandler on Thursday, November 2, 2023. The analyst firm set a price target for 4.50 expecting NSPR to rise to within 12 months (a possible 98.25% upside). 4 analyst firms have reported ratings in the last year.
The stock price for InspireMD (NASDAQ: NSPR) is $2.2699 last updated March 18, 2024 at 3:09 PM EDT.
There are no upcoming dividends for InspireMD.
InspireMD’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for InspireMD.
InspireMD is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.